Blue Water Acquisition Corp.
Status: Deal Closed
U=S+W
W=S@11.5
| IPO Proceeds, $M | $57.50M |
|---|---|
| IPO Date | Dec 15, 2020 |
| CEO | Joseph Hernandez |
| Left Lead | Maxim |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 12+(2*3) |
| IPO Sector |
Healthcare
Life sciences and pharmaceutical services in the US and Europe |
| IPO Geography | Global |
| Target Company | Clarus Therapeutics |
| Deal Announced | Apr 27, 2021 |
| Deal Size, $M | $215.90M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Aug 27, 2021 |
| Amendment Vote | TBD |
| Closing Date | Sep 9, 2021 |
Formerly BLUW
CRXTQ
CRXTW
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Blue Water Acquisition Corp.:
- Structure and cap table
- 6 directors & officers
- 19 filings and events
- 1 underwriters
- 5 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Joseph Hernandez | 48 | Chairman and CEO |
| Jon Garfield | 56 | CFO |
| Kimberly Murphy | 58 | Director |
| James Sapirstein | 59 | Director |
| Michael Lerner | 62 | Director |
| Yvonne McBurney | 56 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Maxim | BR | 5,000,000 | units |
| 5,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.